Holger Weis
Director, ZIOPHARM Oncology.
Companies
- ZIOPHARM OncologyChief executive officer Jul 7, 2025 to now1
- JUPITER NEUROSCIENCES, INC.Board member Nov 8, 2024 to now2
- ZIOPHARM OncologyBoard member Mar 22, 2021 to now3
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- JUPITER NEUROSCIENCES, INC. JUNS96,581 shares4$303.3K at $3.14Jun 2, 2025
- ZIOPHARM Oncology TCRT25,683 shares5$56.0K at $2.18Aug 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 6, 2026Granted 4,363 shares at $2.01 of ZIOPHARM Oncology5
- Jul 23, 2026Granted 4,568 shares at $1.92 of ZIOPHARM Oncology6
- Jun 30, 2026Granted 3,880 shares at $2.26 of ZIOPHARM Oncology7
- Jun 12, 2026Granted 7,761 shares at $2.26 of ZIOPHARM Oncology8
- May 22, 2026Granted 3,700 shares at $2.37 of ZIOPHARM Oncology9
- Jun 2, 2025Exercised options 85,800 shares of JUPITER NEUROSCIENCES, INC.4
- Jan 22, 2025Exercised options 10,781 shares of JUPITER NEUROSCIENCES, INC.10
- Jun 22, 2022Granted 40,000 shares of ZIOPHARM Oncology11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARZIOPHARM Oncology, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Jul 27, 2026
- 7SEC EDGARForm 4 filed Jul 2, 2026
- 8SEC EDGARForm 4 filed Jun 17, 2026
- 9SEC EDGARForm 4 filed May 27, 2026
- 10SEC EDGARForm 4 filed Jan 24, 2025
- 11SEC EDGARForm 4 filed Jun 24, 2022